Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (531-540 of 622) with videos related to

Pageof 63
Sort By:
QJM : Monthly Journal of the Association of Physicians|January 4, 2019
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and OpportunitiesAryeh Fischer, Mary E Strek, Vincent Cottin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 14, 2025
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypesJavier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
The Journal of Investigative Dermatology|November 29, 2017
Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic SclerosisTobias C Messemaker, Loubna Chadli, Guoshuai Cai, et al.
Rheumatology (Oxford, England)|January 8, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohortEliane Roth, Cosimo Bruni, Liubov Petelytska, et al.
The Lancet. Rheumatology|May 17, 2025
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort studyAnna-Maria Hoffmann-Vold, Liubov Petelytska, Håvard Fretheim, et al.
Nature Medicine|July 18, 2017
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cellsSimon Rauber, Markus Luber, Stefanie Weber, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|October 11, 2024
EULAR recommendations for the treatment of systemic sclerosis: 2023 updateFrancesco Del Galdo, Alain Lescoat, Philip G Conaghan, et al.
Rheumatology (Oxford, England)|April 11, 2026
Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenonCarlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Carlos Rosa-Baez, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
Pageof 63

Showing results (531-540 of 622) with videos related to

Sort By:
Pageof 63
QJM : Monthly Journal of the Association of Physicians|January 4, 2019
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and OpportunitiesAryeh Fischer, Mary E Strek, Vincent Cottin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 14, 2025
Distinct effects of complement C4A and C4B copy number in Systemic Sclerosis serological and clinical subtypesJavier Martínez-López, Carlos Rangel-Peláez, Inmaculada Rodriguez-Martin, et al.
The Journal of Investigative Dermatology|November 29, 2017
Antisense Long Non-Coding RNAs Are Deregulated in Skin Tissue of Patients with Systemic SclerosisTobias C Messemaker, Loubna Chadli, Guoshuai Cai, et al.
Rheumatology (Oxford, England)|January 8, 2025
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohortEliane Roth, Cosimo Bruni, Liubov Petelytska, et al.
The Lancet. Rheumatology|May 17, 2025
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort studyAnna-Maria Hoffmann-Vold, Liubov Petelytska, Håvard Fretheim, et al.
Nature Medicine|July 18, 2017
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cellsSimon Rauber, Markus Luber, Stefanie Weber, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|October 11, 2024
EULAR recommendations for the treatment of systemic sclerosis: 2023 updateFrancesco Del Galdo, Alain Lescoat, Philip G Conaghan, et al.
Rheumatology (Oxford, England)|April 11, 2026
Novel pleiotropic loci links vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenonCarlos Rangel-Peláez, Inmaculada Rodriguez-Martin, Carlos Rosa-Baez, et al.
International Journal of Cardiology|November 21, 2012
Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registryMarius M Hoeper, Doerte Huscher, H Ardeschir Ghofrani, et al.
Pageof 63